Applications for a three-year grant are invited from interested individuals and teams from not-for-profit research organisations.

The call is for one grant in any branch of science and technology for cutting-edge ​“Bench to Bedside” translational projects leading to interventions that improve the health of individuals and the public. Any project designed to address a focused disease related topic with cutting-edge techniques and analysis resulting in translational solutions to illness or clinical problems will be eligible to apply. 

However, climate change, agricultural sciences and ecological sciences are excluded from the ambit of this call.

SreePVF expects that proposals submitted under this funding initiative describe ambitious projects that lead to substantial benefit to human health with measurable impact. The grant is envisaged as an enabler to deliver ready to deploy solutions which can lead to successful bed-side applications. A key requirement of the grant is that the proposed research should, by the end of the 3‑year grant period, lead to tangible outcomes, that can immediately be translated into innovative tools/​products/​treatments/​interventions that are easily accessible and cost-effective, thus benefitting large sections of the population. 

Proposals for less than three years will not be considered

PhD/​MD/​MS or Equivalent

Soft copies of the duly filled in application must be emailed as a single consolidated PDF file with all necessary signatures to sreepvfgrants@​gmail.​com. The file name of the submitted application should be the full name of the lead applicant in the format ​“first name last name.pdf”.

Hard copies are not required. Applicants are requested to take due diligence in filing up the form and provide necessary information as required. Short listed candidates would be required to present research proposal before a selection committee through an on-line presentation.

The form is available to download from here

The deadline for receipt of the three-year proposal is 18August, 2022.

For more details click here